D. Couch

Agonist-Selective Mechanisms of μ-Opioid Receptor Desensitization in Human Embryonic Kidney 293 Cells

S. Mundell, S. Oldfield, E. Kelly, 2006, Molecular Pharmacology.

Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.

C. Ortori, S. O'Sullivan, D. Couch, 2019, Inflammatory bowel diseases.

Fasting and surgery timing (FaST) audit

D. Lobo, A. Nessa, J. Lund, 2020, Clinical nutrition.

Real World Evidence in Medical Cannabis Research

Rishi Banerjee, M. Sodergren, S. Erridge, 2021, Therapeutic Innovation & Regulatory Science.

The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

S. O'Sullivan, H. Maudslay, B. Doleman, 2018, Inflammatory bowel diseases.

Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα.

C. Tufarelli, S. O'Sullivan, M. Larvin, 2019, Biochemical pharmacology.

Access to cannabidiol without a prescription: A cross-country comparison and analysis.

I. McGregor, J. Arnold, D. Couch, 2020, The International journal on drug policy.

The role of CB1 in intestinal permeability and inflammation

D. Barrett, K. Wright, S. O'Sullivan, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The role of CB 1 in intestinal permeability & inflammation

D. Barrett, K. Wright, S. O'Sullivan, 2017 .

Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.

S. O'Sullivan, D. Couch, E. Theophilidou, 2017, Clinical science.

μ-Opioid Receptor Desensitization in Mature Rat Neurons: Lack of Interaction between DAMGO and Morphine

E. Kelly, G. Henderson, C. Bailey, 2003, The Journal of Neuroscience.